SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-23-013650
Filing Date
2023-02-22
Accepted
2023-02-22 16:00:17
Documents
12
Period of Report
2023-02-16
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea173958-8k_inmunebio.htm   iXBRL 8-K 40970
  Complete submission text file 0001213900-23-013650.txt   220699

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE inmb-20230216.xsd EX-101.SCH 3230
3 XBRL LABEL FILE inmb-20230216_lab.xml EX-101.LAB 34916
4 XBRL PRESENTATION FILE inmb-20230216_pre.xml EX-101.PRE 22791
6 EXTRACTED XBRL INSTANCE DOCUMENT ea173958-8k_inmunebio_htm.xml XML 3881
Mailing Address 225 NE MIZNER BLVD, SUITE 640 BOCA RATON FL 33432
Business Address 225 NE MIZNER BLVD, SUITE 640 BOCA RATON FL 33432 8589643720
Inmune Bio, Inc. (Filer) CIK: 0001711754 (see all company filings)

IRS No.: 475205835 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38793 | Film No.: 23652989
SIC: 2836 Biological Products, (No Diagnostic Substances)